Boiron Ducks Class Cert. In Suit Over Flu Remedy Label

Law360, New York (February 28, 2014, 1:38 PM EST) -- A California federal judge shut down class certification efforts Thursday in a suit arguing that a $12 million consumer settlement with homeopathic medicine maker Boiron Inc. failed to alleviate false advertising surrounding its Oscillococcinum flu symptom remedy, saying the lead plaintiff lacked credibility on a critical issue.

U.S. District Judge Stephen V. Wilson determined that plaintiff Leonidas Jovel’s erratic deposition testimony on whether he relied on the Oscillo product’s labeling in his purchasing decision diminished his likelihood of prevailing on class action claims and rendered him an...
To view the full article, register now.




Case Information

Case Title

Christopher Lewert v. Boiron Inc et al

Case Number



California Central

Nature of Suit

Other Statutory Actions


Andre Birotte Jr

Date Filed

December 29, 2011

Law Firms

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.